EpiCube is not just another epidemiology database.
With extensive datasets and Power BI-driven, dynamic reports, it transforms traditional data analysis into a visually immersive journey. Unlike sifting through Excel files or databases, EpiCube provides a more engaging and intuitive way to explore epidemiology data, supporting your forecasting.
We have designed EpiCube to enable effortless filtering of data by specific diseases, providing both macro and micro-level analyses. Its user-friendly interface allows you to visually explore disease-specific details, such as incidence rates, biomarkers, and gender splits, making analysis quicker and less error-prone compared to traditional methods.
EpiCube Coverage
- Access to over 250 diseases across 50 markets.
- Over 30 specific oncology tumour types (both solid and liquid).
- Nearly 10,000 subpopulations, including gender splits, age groups, and severity categories.
In terms of coverage for oncology forecasting, EpiCube stands out, offering unrivalled analytical capabilities.
Explore and analyse your data, filtering by various criteria. The granular detail goes beyond incidence and prevalence rates to include factors like country, gender splits, age groups, and severity categories, facilitating a detailed exploration of the dataset.
EpiCube for Market Research
EpiCube is a valuable tool for both secondary and primary market research.
Secondary Research
- Profile countries, diseases, or subpopulations efficiently for comprehensive assessments and due diligence.
Primary Research
- Quantify share of market outputs from doctor interviews into absolute patient numbers, enhancing the accuracy of forecasting.
EpiCube’s flexibility allows the extraction of data into Excel or CSV files while maintaining the efficiency and clarity of Power BI reports. In-built AI helps you to explore data deviations, for error-free analysis.
Created by the experts at J+D with pharmaceutical forecasting structures in mind, easily align your EpiCube data with your forecast with complete transparency, providing confidence in both the inputs and outputs of your forecast.
